Guideline Profile : Diabetic macular oedema
You are here : Home > Formulary Search > Guideline Profile : Diabetic macular oedema
Documentation
Guidelines (National)
Drugs
Below are listed all drugs that are used to treat Diabetic macular oedema.
Committee Recommendations (1)
APC agreed to adopt the NHSE pathway for Diabetic Macular Oedema
Guideline Profile
Indication :
Diabetic macular oedema
Keywords :
DMO, Retinal Services, Ophthalmology, Aflibercept, ranibizumab, biosimilar, faricimab, brolucizumab, fluocinolone acetonide, dexamethasone, intravitreal injection,
Brand Names Include :
Ozurdex, Beovu, Iluvien, Lucentis, Ongavia, Ximluci, Byooviz, Rimmyrah, Afqlir, Vabysmo, Eylea
Important Information :
Latest Additions Date From :
03 Dec 2025
Latest Additions Date To :
31 Dec 2025
Supporting Documents :
1